Literature DB >> 29922883

Management of Cardiac Arrest in the Pregnant Patient.

Natalie Stokes1, Jacqueline Kikucki2.   

Abstract

PURPOSE OF REVIEW: The goal of this review is to elucidate what is known about the science of maternal resuscitation and how treatment guidelines have developed to optimize management. RECENT
FINDINGS: There is limited data on maternal cardiac arrest. Case reports are providing some insight into safety and efficacy of certain mechanisms of treatment, including use of extracorporeal membranous oxygenation and thrombolysis, for example. Data increasingly supports the preventability of a significant portion of maternal cardiac arrest, which remains the most important target for intervention. maternal cardiac arrest has increased in incidence over the past several decades but remains a rare event. In recent years, guidelines have emerged in attempt to standardize treatment, although research on best practice is scarce. Ultimately, future progress in targeting the rise in rate of cardiac arrest will come from large scale collaboration in data sharing and development of mechanisms to identify at risk patients to prevent arrest.

Entities:  

Keywords:  Maternal cardiac arrest; Maternal resuscitation; Perimortem cesarean delivery

Year:  2018        PMID: 29922883     DOI: 10.1007/s11936-018-0652-9

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  55 in total

1.  Ten years of confidential inquiries into maternal deaths in France, 1998-2007.

Authors:  Monica Saucedo; Catherine Deneux-Tharaux; Marie-Hélène Bouvier-Colle
Journal:  Obstet Gynecol       Date:  2013-10       Impact factor: 7.661

2.  Implementing emergency manuals: can cognitive aids help translate best practices for patient care during acute events?

Authors:  Sara N Goldhaber-Fiebert; Steven K Howard
Journal:  Anesth Analg       Date:  2013-11       Impact factor: 5.108

3.  Advisory statements of the International Liaison Committee on Resuscitation (ILCOR) CPR in pregnancy.

Authors:  M S Takrouri; M A Seraj; A B Channa
Journal:  Middle East J Anaesthesiol       Date:  1998-10

Review 4.  Maternal cardiac arrest and perimortem caesarean delivery: evidence or expert-based?

Authors:  Sharon Einav; Nechama Kaufman; Hen Y Sela
Journal:  Resuscitation       Date:  2012-05-18       Impact factor: 5.262

Review 5.  Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment.

Authors:  L Bartalena; F Bogazzi; L E Braverman; E Martino
Journal:  J Endocrinol Invest       Date:  2001-02       Impact factor: 4.256

Review 6.  Perimortem cesarean delivery: were our assumptions correct?

Authors:  Vern Katz; Keith Balderston; Melissa DeFreest
Journal:  Am J Obstet Gynecol       Date:  2005-06       Impact factor: 8.661

7.  Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom.

Authors:  Roch Cantwell; Thomas Clutton-Brock; Griselda Cooper; Andrew Dawson; James Drife; Debbie Garrod; Ann Harper; Diana Hulbert; Sebastian Lucas; John McClure; Harry Millward-Sadler; James Neilson; Catherine Nelson-Piercy; Jane Norman; Colm O'Herlihy; Margaret Oates; Judy Shakespeare; Michael de Swiet; Catherine Williamson; Valerie Beale; Marian Knight; Christopher Lennox; Alison Miller; Dharmishta Parmar; Jane Rogers; Anna Springett
Journal:  BJOG       Date:  2011-03       Impact factor: 6.531

8.  Hypoxic cardiac arrest in pregnancy due to pulmonary haemorrhage.

Authors:  Ina Grimme; Ralf Winter; Stefan Kluge; Martin Petzoldt
Journal:  BMJ Case Rep       Date:  2012-08-24

Review 9.  Variation of drug kinetics in pregnancy.

Authors:  Petr Pavek; Martina Ceckova; Frantisek Staud
Journal:  Curr Drug Metab       Date:  2009-06       Impact factor: 3.731

Review 10.  Extracorporeal life support during pregnancy.

Authors:  Sarah A Moore; Charles A Dietl; Denise M Coleman
Journal:  J Thorac Cardiovasc Surg       Date:  2015-12-22       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.